Navigation Links
Stryker Hip Recall Update: FDA Announces Launch of New Medical Device Identification System to Better Target Recalls, Improve Patient Safety

New York, NY (PRWEB) September 29, 2013

The U.S. Food and Drug Administration (FDA) is launching a new system for identifying high-risk medical devices, like those affected by the Stryker hip recall ( that it says will target product problems more quickly and improve patient safety, Bernstein Liebhard LLP reports.

According to an update issued September 20th on the FDA’s website, the agency has announced its plans to phase in a new unique device identification system (UDI) that will require each medical device on the market to be labeled with a unique number indicating its model, expiration date and manufacturing date.* The FDA will primarily focus on high-risk medical devices, which may include metal hip implants similar to the now-recalled Stryker Rejuvenate and ABG II modular-neck hip stems, in its program launch. The new system will allow federal regulators to efficiently identify medical devices and improve the accuracy of adverse event reports indicating possible issues with each one, the agency’s notification states.

Meanwhile, recent court records show that over 600 Stryker hip lawsuits brought by individuals who allegedly suffered pain, swelling, metallosis and other debilitating early device failure complications caused by the Rejuvenate and ABG II metal hip implants have been filed in the U.S. These devices were recalled by Stryker Orthopaedics on July 6, 2012.

“We are looking forward to see the FDA phase in this new program. We continue to hear from individuals across the U.S. who allegedly sustained injuries stemming from the Stryker hip recall,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Right now, the Firm is offering free case evaluations for potential Stryker lawsuit claimants who may have sustained pain, swelling, metallosis and other hip failure complications after receiving the Rejuvenate and/or ABG II modular-neck hip stems.

Stryker Hip Recall

Court documents issued in September indicate that Stryker lawsuits are continuing to pile up in both the federal and state proceedings established in the U.S. In a multicounty litigation currently underway in New Jersey’s Bergen County Superior Court, a total of 382 cases alleging injuries caused by the Stryker hip recall have been filed. The lawyers at Bernstein Liebhard LLP are actively filing cases alleging metallosis, necrosis, osteolysis and other artificial hip injuries in this litigation. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

A total of 290 Stryker lawsuits are also pending in a federal proceeding underway in the U.S. District Court, District of Minnesota, which similarly allege that the Stryker Rejuvenate and ABG II hip stems were defectively designed by Stryker Orthopaedics, given the potential for their metal components to fret and corrode at the modular-neck junction. The next status conference in this litigation has been scheduled for November 21st at 9:00 a.m. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
Plaintiffs involved in in both of these proceedings were allegedly forced to undergo revision surgery to remove the metal hip after it failed prematurely.

The Stryker hip recall was announced by the manufacturer on July 6, 2012 after post-market surveillance data revealed the potential for the metal components of the Stryker Rejuvenate and ABG II hip stems to fail early. In the wake of the recall, Stryker Orthopaedics has advised all recipients of these devices to undergo routine medical screening to monitor for the high metal levels in the blood, whether or not they are experiencing symptoms.**

Individuals who may have sustained early hip failure complications stemming from the Stryker hip recall may be eligible to file a lawsuit seeking compensation for out-of-pocket medical bills, as well as lost wages, and pain and suffering. Learn more by speaking directly with a Stryker hip lawyer at Bernstein Liebhard LLP. Free case evaluations may also be obtained by calling 800-511-5092.

* **

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.


Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Olympus, Ethicon, Stryker and Karl Storz Lead the Growing Canadian Endoscopic and Surgical Device Market Valued at Nearly $500 Million, Reports iData Research
2. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey Stryker Hip Recall Litigation
3. Stryker Hip Lawsuits Continue to Mount as Claims in New Jersey Stryker Hip Recall Litigation Approach 400, Bernstein Liebhard LLP Reports
4. Michigan-Based Stryker Corp. and Its Howmedica Osteonics Subsidiary Are Targeted in Defective Hip Implant Lawsuit
5. Stryker Hip Implant News: Rottenstein Law Group LLP Applauds Consumer Reports’ Call for Metal-on-Metal Hip Manufacturer Accountability
6. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conferences in State, Federal Stryker Hip Recall Litigations
7. The FDA Issues Class 1 Recall for Stryker’s Oasys Midline Occiput Plate Due to a Key Defect, Reports Parker Waichman LLP
8. Stryker Hip Lawsuit News: Wright & Schulte LLC Commend Mediation Plan in New Jersey Stryker Hip Replacement Lawsuits
9. Stryker Hip Lawsuit Update: Bernstein Liebhard LLP Notes Additional Progress in Stryker Hip Recall Litigation Underway in New Jersey Superior Court
10. Stryker Hip Replacement Recall Lawyers at Wright & Schulte LLC Report on Growing Number of Stryker Hip Replacement Lawsuits
11. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Case Management Order in New Jersey Stryker Recall Litigation
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An extensive directory ... specialized and only includes chiropractic clinics in the US. , The team at ... health practitioner when back pain sets in. When people are experiencing back and ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... driverless vehicle experience this summer, ushering in a new era of publicly accessible ... and electric shuttle, will continue to offer guests an up-close look at the ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an ... festivities, the Word of Life Christian Church of Flint, MI, hosted a family-oriented ... giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever Recovery, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... across the United States to access life-saving information provided directly from top ... will consist of three individual conferences in three major cities: Houston, San Francisco, ...
(Date:11/30/2015)... ... November 30, 2015 , ... During the week of ... raise funds for its research, education, support, and advocacy efforts. The campaign is ... , The Mesothelioma Applied Research Foundation, which also goes by Meso Foundation, holds ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 North America ... to grow at a CAGR of 7.6% from 2015 to 2020. ... USD 135.6 million in 2014, and is expected to grow at ... According to the new Market Research Report "North America Cardiac Output ... User (Hospitals, ambulatory care, others) - Analysis And Forecast To 2020", ...
(Date:11/30/2015)... , Nov. 30, 2015  Kevin Smith has ... Healthcare, a global pioneer in wireless monitoring of ... Boston, MA , Mr. Smith will be ... global commercial strategy.  He will also directly oversee ... build clinical evidence for SensiumVitals, the first early ...
(Date:11/30/2015)... and SAN DIEGO , Nov. ... Inc. (NASDAQ: ARNA ) today announced that the ... filing the New Drug Application (NDA) for an extended ... formulation will offer patients a chronic weight management treatment ... ) is currently approved as an adjunct to a ...
Breaking Medicine Technology: